LIVER TRANSPLANT
Clinical trials for LIVER TRANSPLANT explained in plain language.
Never miss a new study
Get alerted when new LIVER TRANSPLANT trials appear
Sign up with your email to follow new studies for LIVER TRANSPLANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Vaccine could cut antiviral need after liver transplant
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a vaccine against cytomegalovirus (CMV) given to people before they receive a liver transplant. The goal is to see if the vaccine reduces the amount of antiviral medicine needed after transplant. About 416 participants who are CMV-negative and waiting for a liver…
Matched conditions: LIVER TRANSPLANT
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated May 19, 2026 11:46 UTC
-
New hope for liver cancer patients after transplant failure?
Disease control Recruiting nowThis study tests a drug called cabozantinib in 20 adults whose liver cancer came back after a liver transplant. The goal is to see if the drug can control the cancer and slow its growth. Participants take the drug until it stops working or side effects become too severe.
Matched conditions: LIVER TRANSPLANT
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 26, 2026 06:01 UTC
-
Machine may turn fatty livers into Life-Saving transplants
Disease control Recruiting nowThis study tests whether a special machine can revive fatty donor livers (30-60% fat) so they can be safely transplanted. About 200 adults on the liver transplant list will receive a treated liver. If successful, this could expand the donor pool and help more people get transplan…
Matched conditions: LIVER TRANSPLANT
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 26, 2026 05:47 UTC
-
New hope for liver transplant patients: fewer drugs, healthier kidneys
Disease control Recruiting nowThis study looks at whether liver transplant recipients can safely stop one anti-rejection medicine (tacrolimus) and use only everolimus to protect their kidneys. About 340 adults who received their first liver transplant will take part. The goal is to see if this approach keeps …
Matched conditions: LIVER TRANSPLANT
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 26, 2026 05:46 UTC
-
Apps for a new lease on life: study tests digital coaching for transplant patients
Disease control Recruiting nowThis study tests if a doctor-led counseling program, plus two smartphone apps, can help older adults (60+) who have had a liver or kidney transplant eat better and be more active. Sixty participants will first get lifestyle advice, then use the apps for 12 weeks. The goal is to s…
Matched conditions: LIVER TRANSPLANT
Phase: NA • Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New hope for liver transplant patients with returning cancer: drug combo under study
Disease control Recruiting nowThis study is for liver transplant patients whose liver cancer has come back and cannot be treated with surgery or local therapies. Researchers want to see if a combination of two drugs, Atezolizumab and Bevacizumab, is safe when given with a special plan to prevent organ rejecti…
Matched conditions: LIVER TRANSPLANT
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
Could a drug combo free liver transplant patients from lifelong pills?
Disease control Recruiting nowThis study tests whether two drugs, everolimus and epoetin, can help liver transplant recipients safely stop taking their standard anti-rejection medication (tacrolimus). The goal is to achieve 'operational tolerance,' where the body accepts the new liver without needing lifelong…
Matched conditions: LIVER TRANSPLANT
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
Ear stimulation device may slash opioid use after major surgery
Symptom relief Recruiting nowThis study tests a small, disposable device placed on the ear that stimulates nerves to help manage pain. The goal is to see if it can lower the amount of opioids (strong painkillers) needed after open abdominal or pelvic surgery. About 286 adults having certain cancer or liver t…
Matched conditions: LIVER TRANSPLANT
Phase: NA • Sponsor: Jacques E. Chelly • Aim: Symptom relief
Last updated May 22, 2026 13:52 UTC
-
Sugar sensors after surgery: can monitoring glucose boost transplant success?
Knowledge-focused Recruiting nowThis study follows 40 liver transplant patients after they leave the hospital, using a continuous glucose monitor to track their blood sugar levels. The goal is to see how well blood sugar is controlled and whether that affects transplant outcomes like wound healing or complicati…
Matched conditions: LIVER TRANSPLANT
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated May 26, 2026 06:00 UTC
-
New digital tool aims to ease tough transition for young liver transplant patients
Knowledge-focused Recruiting nowThis study is testing a digital tool to help young people (ages 14–20) who have had or are waiting for a liver transplant as they move from pediatric to adult medical care. The tool is designed to help patients and their families manage their health remotely, reducing the need fo…
Matched conditions: LIVER TRANSPLANT
Sponsor: FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS • Aim: Knowledge-focused
Last updated May 26, 2026 05:51 UTC
-
Are transplant moms' kids at risk? new study investigates long-term health effects
Knowledge-focused Recruiting nowThis study looks at the long-term health of children (16 and older) whose mothers had a solid organ transplant before pregnancy. Researchers want to see if these children have higher risks for heart or kidney problems, possibly due to the mother's anti-rejection medications. Abou…
Matched conditions: LIVER TRANSPLANT
Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated May 11, 2026 20:40 UTC